Compare — Georgia Financials

panel 2026-09-21Ask

Pooled trend

5 companies

Aggregate by year

GEL, thousands · money Σ · ratios from summed bases · growth on the pooled series

Metric	FY 2017	FY 2018	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024
Revenue	101,892	103,703	114,871	141,751	167,884	194,613	214,999	198,372
EBITDA	37,091	27,309	35,965	46,599	53,744	54,896	58,671	49,385
Net profit	32,162	10,748	39,838	55,772	25,766	43,215	57,768	49,087
Total assets	125,812	119,214	148,009	186,089	166,617	160,726	176,227	166,486
n (companies reporting)	3	3	4	4	5	5	5	4

Per-company contribution by year

XLSX

GEL, thousands

Company	FY 2017	FY 2018	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024
CIS Pharma	—	—	—	—	775	34,191	48,230	65,941
Gea	23,510	26,049	30,562	31,602	33,640	37,829	44,821	46,251
Ivermedi	38,283	37,807	43,045	39,797	46,802	38,550	47,124	45,937
Welfare International	40,099	39,847	41,264	57,465	66,163	46,044	29,690	40,243
Mermisi	—	—	0	12,886	20,504	37,998	45,135	—

Rows are the raw pool — every peer, including any excluded from the sums above, so the de-duplication stays auditable. Tinted cells are the excluded company-years.

Peer coverage varies by year — FY2017–FY2020, FY2024 pool fewer than the 5 picked companies (see the n row). A year is never dropped because one peer is missing.

Pooled figures sum every peer in the set. Known parent/subsidiary groups that file separately are de-duplicated; groups not yet curated may still be counted more than once.